NEW YORK, July 7, 2016 /PRNewswire/ --
Stock-Callers.com's focus this morning is on the Medical Appliances and Equipment industry, which can expect strong growth for the remainder of this year despite headwinds. We look at the featured companies for today and review their recent performances: St. Jude Medical Inc. (NYSE: STJ), ResMed Inc. (NYSE: RMD), Steris PLC (NYSE: STE), and Varian Medical Systems Inc. (NYSE: VAR). Learn more about these stocks and receive your complimentary notes at:
To access Stock-Callers.com full Notes for free, please visit the links below.
Full Links to Notes
(You may have to copy and paste the links into your browser)
St. Paul, Minnesota headquartered St. Jude Medical Inc.'s stock finished Wednesday's session 1.66% higher at $79.43 with a total volume of 1.91 million shares traded. The Company's shares have advanced 2.05% in the past month, 42.90% over the previous three months, and 29.86% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 4.93% and 26.58%, respectively. Furthermore, shares of St. Jude Medical, which together with its subsidiaries, develops, manufactures, and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas globally, have a Relative Strength Index (RSI) of 67.12.
On Wednesday, shares in San Diego, California headquartered ResMed Inc. ended the session at $63.91, up 0.49%. The stock recorded a trading volume of 1.05 million shares, which was above its three months average volume of 842,030 shares. The Company's shares have gained 6.77% in the last one month, 7.93% over the previous three months, and 20.29% since the start of this year. The stock is trading 8.55% above its 50-day moving average and 12.86% above its 200-day moving average. Moreover, shares of ResMed, which develops, manufactures, distributes, and markets medical equipment for the diagnosis, treatment, and management of respiratory disorders with a focus on sleep-disordered breathing, have an RSI of 65.09.
Leicester, the U.K. headquartered Steris PLC's stock ended yesterday's session 0.41% higher at $68.07 and with a total volume of 730,092 shares traded. The Company's shares are trading 1.87% below their 200-day moving average. Shares of Steris, which develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers globally, have an RSI of 49.36.
At the close on Wednesday, shares in Palo Alto, California headquartered Varian Medical Systems Inc. recorded a trading volume of 657,053 shares. The stock finished 1.15% higher at $82.74. The Company's shares have gained 1.04% in the previous three months and 2.40% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 0.10% and 4.05%, respectively. Furthermore, shares of Varian Medical Systems, which designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions globally, have an RSI of 52.59.
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com . Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: firstname.lastname@example.org Phone number: +44 330 808 3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA